RxDoctor Payments Data

Dympna Coll, MD

Obstetrics & Gynecology · Barrington, ILNPI 1972531549

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.5% of the total across 250 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 40 manufacturers, the largest accounting for just 10.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $1,287 and has fallen 58.7% since, to $531 in 2025. Among obstetrics & gynecology clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,935in general payments, 2019–2025

Across 250 payments — averaging $19.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$530
  • Amgen$369
  • Astellas Pharma US Inc$287
  • Shield Therapeutics Inc$279
  • Novo Nordisk$279
  • Hologic Sales And Service, LLC$258
  • plus $3K from 34 others

What the payments were for

  • Food & beverage$4,81097%
  • Education$1253%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,935 in reported general payments places this provider in the 90th percentile of 1,732 obstetrics & gynecology providers in Illinois.

See all obstetrics & gynecology providers in Illinois →

Medicare billing

Part B allowed, 2024
$2,621
Medicare patients
15
Services billed
20

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol48$2,766
Ibandronate Sodium28$612
Clobetasol Propionate14$474
Raloxifene Hcl11$390

Paid to pharmacies, not to this prescriber.

Other obstetrics & gynecology in Barrington

See the full list for Illinois →

Where these figures come from

Is this you, or does something look wrong? →